dimethylphenylpiperazinium iodide has been researched along with Hyperglycemia in 1 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jall, S | 1 |
De Angelis, M | 1 |
Lundsgaard, AM | 1 |
Fritzen, AM | 1 |
Nicolaisen, TS | 1 |
Klein, AB | 1 |
Novikoff, A | 1 |
Sachs, S | 1 |
Richter, EA | 1 |
Kiens, B | 1 |
Schramm, KW | 1 |
Tschöp, MH | 1 |
Stemmer, K | 1 |
Clemmensen, C | 1 |
Müller, TD | 1 |
Kleinert, M | 1 |
1 other study available for dimethylphenylpiperazinium iodide and Hyperglycemia
Article | Year |
---|---|
Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity.
Topics: Animals; Blood Glucose; Catecholamines; Dimethylphenylpiperazinium Iodide; Hyperglycemia; Insulin Re | 2020 |